Skip to main content
Clinical Trials/ChiCTR-ROC-17012227
ChiCTR-ROC-17012227Active, not recruitingNot Applicable

卒中后认知功能障碍的早期诊断与临床观察

江苏省重点研发计划1 site in 1 country800 target enrollmentStarted: August 10, 2017Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
800
Locations
1
Primary Endpoint
神经功能缺损评估

Study Overview

Brief Summary

研发卒中后认知功能障碍早期精准诊断技术;筛选出精准治疗的药物。

Study Design

Study Type
病因学/相关因素研究
Primary Purpose
单臂

Eligibility Criteria

Ages
45 to 80 (—)
Sex
All

Inclusion Criteria

  • 1)首次发病, 发病≤72 小时的急性缺血性卒中患者;

Exclusion Criteria

  • 1) 卒中发生之前存在痴呆或严重认知功能障碍;
  • 4) 失语或构音障碍;
  • 5) 严重疾病终末期;
  • 6) 严重抑郁症患者;
  • 7)无法配合高分辨核磁检查。

Arms & Interventions

急性脑卒中组

数据收集和随访

Outcomes

Primary Outcomes

神经功能缺损评估

神经心理学评估

功能磁共振检查

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
江苏省重点研发计划

Study Sites (1)

Loading locations...

Similar Trials